Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Balchem (BCPC) over the last 16 years, with Q3 2025 value amounting to $363.2 million.

  • Balchem's Total Liabilities fell 1347.36% to $363.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $363.2 million, marking a year-over-year decrease of 1347.36%. This contributed to the annual value of $425.5 million for FY2024, which is 2167.95% down from last year.
  • As of Q3 2025, Balchem's Total Liabilities stood at $363.2 million, which was down 1347.36% from $410.3 million recorded in Q2 2025.
  • In the past 5 years, Balchem's Total Liabilities ranged from a high of $737.1 million in Q3 2022 and a low of $290.3 million during Q3 2021
  • Moreover, its 5-year median value for Total Liabilities was $425.5 million (2024), whereas its average is $477.6 million.
  • As far as peak fluctuations go, Balchem's Total Liabilities surged by 15393.03% in 2022, and later plummeted by 2741.17% in 2024.
  • Balchem's Total Liabilities (Quarter) stood at $322.3 million in 2021, then surged by 112.91% to $686.2 million in 2022, then fell by 20.84% to $543.2 million in 2023, then fell by 21.68% to $425.5 million in 2024, then dropped by 14.64% to $363.2 million in 2025.
  • Its Total Liabilities stands at $363.2 million for Q3 2025, versus $410.3 million for Q2 2025 and $408.9 million for Q1 2025.